Cancer is a pivotal disease, which is a serious concern towards scientific research.
In the recent era of scientific discovery and innovation, probiotics have been proposed
as a new preventive and therapeutic option in therapy and to control cancer growth.
Probiotics may thus offer a new way in research to investigate active compounds in different
probiotic strains having anticancer features. Studies in laboratory animals and cell lines
with respect to cancer treatments are encouraging. With rare conventional treatments, the
need for new alternatives as the transportation of chemotherapeutic agents by nanocarriers
using nanotechnology is one such approach. This review considers various drug delivery
systems used in the therapy of cervical cancer, such as dendrimers, liposomes and nanoparticles.
These drug delivery systems assist in the improvement of pharmacological activity,
solubility, bioavailability and, thus, facilitating new innovative therapeutic technologies.
This review summarizes the application of nanotechnology and probiotics in the treatment
of cervical cancer.